Paganini Competition

CareCoin (CARE) Is Now Available for Trading on LBank Exchange

Retrieved on: 
Monday, December 5, 2022
STARS, Exosome, Nobel Prize, Cell, Diagnosis, Blockchain, Silicon, Cell bank, Personalization, Marketing, Doctor, CLINIC, Ecosystem, Paganini Competition, NMN, IPS, Kyoto University, CARE, Attention, NFT, BNCT, Non-fungible token, Cryptocurrency, Medical device, AI

Internet City, Dubai--(Newsfile Corp. - December 4, 2022) - LBank Exchange, a global digital asset trading platform, has listed CareCoin (CARE) on December 5, 2022.

Key Points: 
  • Internet City, Dubai--(Newsfile Corp. - December 4, 2022) - LBank Exchange, a global digital asset trading platform, has listed CareCoin (CARE) on December 5, 2022.
  • For all users of LBank Exchange, the CARE/USDT trading pair is now officially available for trading.
  • Its native token CareCoin (CARE) has been listed on LBank Exchange at 7:00 UTC on December 5, 2022, to further expand its global reach and help it achieve its vision.
  • The CARE token has been listed on LBank Exchange at 7:00 UTC on December 5, 2022, investors who are interested in the CARE platform investment can easily buy and sell CARE token on LBank Exchange now.

Vingroup: VinFuture announces the event series of VinFuture Sci-Tech Week 2022

Retrieved on: 
Sunday, December 18, 2022
Lithium, Elan d'or Award Special Prize, Nobel Prize, Life, Hanoi Opera House, Create, Student, NEWS, European Association for the Study of Diabetes, Discovery, Bachelor of Engineering, US, Zhejiang Sci-Tech University, Science, Invention, Millennium Technology Prize, University of California, Davis, Korean House for International Solidarity, Female, Education, STEM, Paganini Competition, Perelman School of Medicine at the University of Pennsylvania, Stanford University, University of Cambridge, CNN, Clean technology, Argonne National Laboratory, Convention center, University, Agriculture, University of Pennsylvania, Video game, Pharmaceutical industry, Powder metallurgy, Security (finance), Euronews, Physics

HA NOI, VIETNAM - Media OutReach - 13 December 2022 – VinFuture Foundation officially announces the agenda of the second VinFuture Sci-Tech Week, taking place between December 17–21, 2022 in Hanoi.

Key Points: 
  • HA NOI, VIETNAM - Media OutReach - 13 December 2022 – VinFuture Foundation officially announces the agenda of the second VinFuture Sci-Tech Week, taking place between December 17–21, 2022 in Hanoi.
  • Taking place over five days, the event series includes: “Conversation with the VinFuture Prize Council and Pre-screening Committee”; “Innovate Today, Create Tomorrow” Inspirational Talk Series; “Science for Life Symposium”; “VinFuture Prize Award Ceremony”; and “Talk Future: A dialogue with the 2022 VinFuture Prize Laureates”.
  • The main event of the week is the 2022 VinFuture Prize Award Ceremony – Reviving and Reshaping – held in the evening of December 20, 2022, at the Hanoi Opera House to honor the next VinFuture laureates.
  • Closing the VinFuture Sci-Tech Week is Talk Future: A dialogue with the 2022 VinFuture Prize Laureates, which will take place throughout the day on December 21, 2022.

Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer

Retrieved on: 
Thursday, December 15, 2022
Faculty, Allison, Medical Affairs Bureau, Pritzker School of Medicine, Alpert Medical School, Pregnancy, Chicago (franchise), Paganini Competition, Sirna, Comanche, Patient, Death, Immunization, Disease, Woman, CMV, COVID-19, History, Brown University, Premature, Self-signed certificate, Vaccine, Drug, University, RSV, Mortality, Infant, Health, Harvard Medical School, Bryn Mawr College, Gynaecology, Pharmaceutical industry, Chikungunya, Diagnosis, Pre-eclampsia, Obstetrics, Moderna, Novavax

CONCORD, Mass., Dec. 15, 2022 /PRNewswire/ -- Comanche Biopharma , a preclinical biopharmaceutical company developing a novel siRNA therapy for the treatment of preeclampsia, today announced that maternal health, vaccine and drug development expert Allison August, M.D., has been appointed as the companys Chief Medical Officer.

Key Points: 
  • CONCORD, Mass., Dec. 15, 2022 /PRNewswire/ -- Comanche Biopharma , a preclinical biopharmaceutical company developing a novel siRNA therapy for the treatment of preeclampsia, today announced that maternal health, vaccine and drug development expert Allison August, M.D., has been appointed as the companys Chief Medical Officer.
  • "We are very pleased to have Allison join Comanche.
  • Her academic career included faculty positions at the Brown University Medical School and adjunctive faculty at Harvard Medical School affiliated hospitals.
  • "We are at a unique moment when an effective treatment for preeclampsia may finally be within medical reach," said Johnson.

Hans Sy recognized as Outstanding Filipino for resilience and sustainability efforts

Retrieved on: 
Wednesday, December 14, 2022
Character, Filipino, Rehabilitation, Capacity building, Popular Executive Committee of Valencia, Paganini Competition, Radio Philippines Network, Civil service, Executive Committee, SM, COVID-19, Nobel Prize, Disaster, SM Prime, SM Investments, Diversified Specialty Institute Holdings, Inc., JCI, Risk, Mobile phone

PASAY CITY,Philippines, Dec. 14, 2022 /PRNewswire/ -- SM Prime Holdings Inc.'s Hans T. Sy was recognized for his contribution to nation-building and resiliency in the country through sustainability and disaster risk reduction at The Outstanding Filipino (TOFIL) Awards 2022.

Key Points: 
  • PASAY CITY,Philippines, Dec. 14, 2022 /PRNewswire/ -- SM Prime Holdings Inc.'s Hans T. Sy was recognized for his contribution to nation-building and resiliency in the country through sustainability and disaster risk reduction at The Outstanding Filipino (TOFIL) Awards 2022.
  • Sy's recognition comes from his success in integrating sustainability and resilience in the framework of the SM Group's operations.
  • Sy has also helped in the formation of the ARISE Philippine Network, which fosters more public-private sector partnerships for capacity building, technological innovation, and sustainability in underserved communities.
  • "My father, the late Henry Sy Sr., taught us a multitude of lessons growing up, one of them being the importance of goodwill and inclusivity.

Hans Sy recognized as Outstanding Filipino for resilience and sustainability efforts

Retrieved on: 
Wednesday, December 14, 2022
Character, Filipino, Rehabilitation, Capacity building, Popular Executive Committee of Valencia, Paganini Competition, Radio Philippines Network, Civil service, Executive Committee, SM, COVID-19, Nobel Prize, Disaster, Multimedia, SM Prime, SM Investments, Kirkbi AG v Ritvik Holdings Inc, JCI, Risk, Mobile phone

PASAY CITY,Philippines, Dec. 14, 2022 /PRNewswire/ -- SM Prime Holdings Inc.'s Hans T. Sy was recognized for his contribution to nation-building and resiliency in the country through sustainability and disaster risk reduction at The Outstanding Filipino (TOFIL) Awards 2022.

Key Points: 
  • PASAY CITY,Philippines, Dec. 14, 2022 /PRNewswire/ -- SM Prime Holdings Inc.'s Hans T. Sy was recognized for his contribution to nation-building and resiliency in the country through sustainability and disaster risk reduction at The Outstanding Filipino (TOFIL) Awards 2022.
  • Sy's recognition comes from his success in integrating sustainability and resilience in the framework of the SM Group's operations.
  • Sy has also helped in the formation of the ARISE Philippine Network, which fosters more public-private sector partnerships for capacity building, technological innovation, and sustainability in underserved communities.
  • "My father, the late Henry Sy Sr., taught us a multitude of lessons growing up, one of them being the importance of goodwill and inclusivity.

ANNUAL BERGGRUEN PRIZE FOR PHILOSOPHY & CULTURE AWARDED TO JAPANESE PHILOSOPHER KOJIN KARATANI

Retrieved on: 
Thursday, December 8, 2022
Kojin Karatani, Origin, Democracy, LOS, Exercise, Linguistics, Vocabulary, Yale University, Society, Kindai University, Animal rights, Repetition, Government, History, Berggruen Institute, Anger, Paganini Competition, Immanuel Kant, Berggruen, University of California, Los Angeles, Civilization, Humanities, University, Movement, Fukushima Daiichi nuclear disaster, Poverty, Public health, Noema, University of Tokyo, Essay, Metaphor, Structure, BBC, Berggruen Prize, Thought, Prize, Fear, Capitalism, Altruism, Literature, Social, Columbia University, Education, Hosei University, Research, Economics, BBC World Service, Gunzo, Management, Language, Philosophy, Architecture

TOKYO and LOS ANGELES, Dec. 8, 2022 /PRNewswire/ -- Today, the Berggruen Prize Jury announced its selection of preeminent Japanese philosopher and literary critic Kojin Karatani as the winner of the 2022 Berggruen Prize for Philosophy & Culture. The $1 million award is given annually to thinkers whose ideas have profoundly shaped human self-understanding and advancement in a rapidly changing world. Karatani is the first Asian laureate of the Berggruen Philosophy & Culture Prize, a rare thinker whose ideas move across philosophy, literary theory, aesthetics, linguistics, economics, and politics—East and West; past and present. The Berggruen Prize Jury has selected Kojin Karatani for his "radically original contributions to modern philosophy, the history of philosophy, and political thinking—making Karatani's work particularly valuable in the current era of troubled global capitalism, crisis in democratic states, and resurgent but seldom self-critical nationalism."

Key Points: 
  • TOKYO and LOS ANGELES, Dec. 8, 2022 /PRNewswire/ -- Today, the Berggruen Prize Jury announced its selection of preeminent Japanese philosopher and literary critic Kojin Karatani as the winner of the 2022 Berggruen Prize for Philosophy & Culture.
  • Karatani is the first Asian laureate of the Berggruen Philosophy & Culture Prize, a rare thinker whose ideas move across philosophy, literary theory, aesthetics, linguistics, economics, and politicsEast and West; past and present.
  • Not an arm-chair philosopher, Kojin Karatani has actively promoted a modern form of the kind of reciprocity he saw in ancient Ionian culture, which he calls 'associationism,'" said Berggruen Institute Chairman Nicolas Berggruen.
  • Karatani will receive the Berggruen Prize for Philosophy & Culture in Spring 2023 in a celebration to be held in Tokyo, Japan.

ANNUAL BERGGRUEN PRIZE FOR PHILOSOPHY & CULTURE AWARDED TO JAPANESE PHILOSOPHER KOJIN KARATANI

Retrieved on: 
Thursday, December 8, 2022
Kojin Karatani, Origin, Democracy, LOS, Exercise, Linguistics, Vocabulary, Yale University, Society, Powers, Kindai University, Animal rights, Repetition, Government, History, Berggruen Institute, Anger, Paganini Competition, Immanuel Kant, Berggruen, University of California, Los Angeles, Civilization, Humanities, University, Movement, Fukushima Daiichi nuclear disaster, Poverty, Public health, Noema, University of Tokyo, Essay, Metaphor, Structure, BBC, Berggruen Prize, Thought, Prize, Fear, Capitalism, Altruism, Literature, Social, Columbia University, Education, Hosei University, Research, Economics, BBC World Service, Gunzo, Management, Language, Philosophy, Architecture

TOKYO and LOS ANGELES, Dec. 8, 2022 /PRNewswire/ -- Today, the Berggruen Prize Jury announced its selection of preeminent Japanese philosopher and literary critic Kojin Karatani as the winner of the 2022 Berggruen Prize for Philosophy & Culture. The $1 million award is given annually to thinkers whose ideas have profoundly shaped human self-understanding and advancement in a rapidly changing world. Karatani is the first Asian laureate of the Berggruen Philosophy & Culture Prize, a rare thinker whose ideas move across philosophy, literary theory, aesthetics, linguistics, economics, and politics—East and West; past and present. The Berggruen Prize Jury has selected Kojin Karatani for his "radically original contributions to modern philosophy, the history of philosophy, and political thinking—making Karatani's work particularly valuable in the current era of troubled global capitalism, crisis in democratic states, and resurgent but seldom self-critical nationalism."

Key Points: 
  • TOKYO and LOS ANGELES, Dec. 8, 2022 /PRNewswire/ -- Today, the Berggruen Prize Jury announced its selection of preeminent Japanese philosopher and literary critic Kojin Karatani as the winner of the 2022 Berggruen Prize for Philosophy & Culture.
  • Karatani is the first Asian laureate of the Berggruen Philosophy & Culture Prize, a rare thinker whose ideas move across philosophy, literary theory, aesthetics, linguistics, economics, and politicsEast and West; past and present.
  • Not an arm-chair philosopher, Kojin Karatani has actively promoted a modern form of the kind of reciprocity he saw in ancient Ionian culture, which he calls 'associationism,'" said Berggruen Institute Chairman Nicolas Berggruen.
  • Karatani will receive the Berggruen Prize for Philosophy & Culture in Spring 2023 at a celebration to be held in Tokyo, Japan.

EQT partners with Nobel Prize Outreach to inspire and engage global audiences on societal challenges

Retrieved on: 
Thursday, December 1, 2022
Science, Paganini Competition, Student, Climate change, Knowledge, Partnership, Education, Nobel International School Algarve, Nobel Prize, Health, Research, EQT, Pharmaceutical industry, Nobel

As a Nobel International Partner, EQT is committed to sharing knowledge, science and research, by encouraging cross-disciplinary engagement with Nobel Prize Laureates.

Key Points: 
  • As a Nobel International Partner, EQT is committed to sharing knowledge, science and research, by encouraging cross-disciplinary engagement with Nobel Prize Laureates.
  • "EQT looks forward to engaging international audiences in cross-disciplinary dialogue with Nobel Prize Laureates and the scientific community.
  • "Nobel Prize Outreach is thrilled to invite EQT to join a select group of Nobel International Partners.
  • In 2023, EQT will participate in Nobel Prize Outreach events in Sweden, Brazil, United States and South Korea.

Hertz Foundation Announces $5 Million Fellowship Gift Honoring Inventor and Entrepreneur Dr. Nathan Myhrvold

Retrieved on: 
Wednesday, November 30, 2022
Science, Other Science, Continuing, Technology, Philanthropy, Education, Foundation, Other Technology, Princeton University, Hertz Foundation, Invention, Science, Hertz, Paganini Competition, National Medal of Science, University, Astronomy, Nature, Engineering, Fields Medal, Physics, National Medal of Technology and Innovation, Modernist Cuisine, Student, Breakthrough Prize, Bill, Education, Intellectual Ventures, Global health, Nathan, National Medal, Breakthrough Prize in Life Sciences, Nobel Prize, MacArthur Fellows Program, Faculty, UCLA, Health, Research, Microsoft Research, Carey Institute for Global Good, Mathematics, Microsoft, Institute for Disease Modeling, Management, Pharmaceutical industry

It is a rare and profound honor to see this new endowment for Hertz Fellowships launched.

Key Points: 
  • It is a rare and profound honor to see this new endowment for Hertz Fellowships launched.
  • I am hoping that the Hertz Fellows whose education is funded by these fellowships will have even more illustrious careers than Ive managed to have, Dr. Myhrvold said.
  • The great thing about the Hertz Foundation is the thoroughly proven, well-honed machine they have developed over decades to select outstanding graduate students.
  • The initial recipients of the Nathan P. Myhrvold Fellowship will be chosen from the 2022 applicants and announced in May 2023.

4D Molecular Therapeutics Announces Interim Clinical Data from On-going Phase 1/2 Clinical Trial of Intravitreal 4D-150 for Wet Age-Related Macular Degeneration (wet AMD)

Retrieved on: 
Monday, November 14, 2022
Clinical trial, Principal, Safety, Security (finance), DME, VEGF, Diabetic retinopathy, Eye, PRISM, Partner (business rank), Blood, Webcast, AAV, Retina, Cystic fibrosis, Conference, Paganini Competition, Clinical research, Choroideremia, CNV, Inflammation, M.A, University, AMD, Fabry disease, Choroidal neovascularization, Molecule, R100, Hallucination, Macular degeneration, Therapy, US, Swelling, Severe cognitive impairment, University of Nevada, Reno, Ophthalmology, Injection, Fabry, Edema, Nobel, RNA interference, Bleeding, Tissue, Risk, Conference call, Cardiology, Scar, Patient, Medical device, Pharmaceutical industry, Vaccine, Placental growth factor

4D Molecular Therapeutics will host a conference call today, Monday November 14, 2022 at 8:00 AM E.T.

Key Points: 
  • 4D Molecular Therapeutics will host a conference call today, Monday November 14, 2022 at 8:00 AM E.T.
  • This clinical data on 4D-150 marks an important milestone for 4DMT, said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.
  • We are developing 4D-150 for the treatment of large and sustainable markets in ophthalmology, including wet AMD and diabetic macular edema.
  • I am looking forward to enrolling patients in the randomized Phase 2 expansion stage of this clinical trial.